Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 19765399)

Published in Vaccine on September 16, 2009

Authors

Jacob Vaya1, Elina Aizenshtein, Soliman Khatib, Tal Gefen, Michael Fassler, Ramadan Musa, Simi Krispel, Jacob Pitcovski

Author Affiliations

1: MIGAL - Galilee Technology Center, Kiryat Shmona 11016, Israel.

Articles citing this

The effect of haptens on protein-carrier immunogenicity. Immunology (2015) 0.78

Articles by these authors

Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem (2003) 2.28

Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers. Phytochemistry (2004) 1.89

Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem (2005) 1.43

Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci (2003) 1.00

Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs. Cancer Res (2008) 0.97

Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. J Med Chem (2007) 0.89

Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy. Phytochemistry (2003) 0.87

Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients. Immunol Lett (2004) 0.87

Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem (2009) 0.85

Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic Biol Med (2006) 0.84

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin. Virology (2012) 0.83

The impact of PEGylation on protein immunogenicity. Int Immunopharmacol (2013) 0.83

Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells. Atherosclerosis (2011) 0.82

Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia. J Neurochem (2008) 0.82

The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study. Bioorg Med Chem (2013) 0.81

Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity. Bioorg Med Chem (2008) 0.81

Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine (2007) 0.80

Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. Free Radic Biol Med (2010) 0.80

A melanoma multiepitope polypeptide induces specific CD8+ T-cell response. Cell Immunol (2008) 0.80

Potential skin antiinflammatory effects of 4-methylthiobutylisothiocyanate (MTBI) isolated from rocket (Eruca sativa) seeds. Biofactors (2009) 0.79

Genetic and antigenic characterization of sigma C protein from avian reovirus. Avian Pathol (2010) 0.79

Glabridin protects paraoxonase 1 from linoleic acid hydroperoxide inhibition via specific interaction: a fluorescence-quenching study. J Agric Food Chem (2012) 0.79

Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker. Biomarkers (2008) 0.79

Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response. Vaccine (2010) 0.79

Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology (2012) 0.79

Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med (2008) 0.79

The effect of haptens on protein-carrier immunogenicity. Immunology (2015) 0.78

Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion. Free Radic Biol Med (2011) 0.78

Immune responses to mucosal vaccination by the recombinant A1 and N proteins of infectious bronchitis virus. Viral Immunol (2012) 0.78

Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response. Cell Immunol (2010) 0.78

Genetic detoxification and adjuvant-activity retention of Escherichia coli enterotoxin LT. Avian Pathol (2006) 0.78

Increased Levels of Human Carotid Lesion Linoleic Acid Hydroperoxide in Symptomatic and Asymptomatic Patients Is Inversely Correlated with Serum HDL and Paraoxonase 1 Activity. J Lipids (2012) 0.78

Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid. Atherosclerosis (2012) 0.78

Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles. Cancer Immunol Immunother (2015) 0.77

Differential stress responses among newly received calves: variations in reductant capacity and Hsp gene expression. Cell Stress Chaperones (2010) 0.76

Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment. Vaccine (2010) 0.75

Human carotid atherosclerotic lesion protein components decrease cholesterol biosynthesis rate in macrophages through 3-hydroxy-3-methylglutaryl-CoA reductase regulation. Biofactors (2015) 0.75

An exogenous marker: a novel approach for the characterization of oxidative stress. Bioorg Med Chem (2007) 0.75

Immunological complex for enhancement of innate immune response in passive vaccination. Vaccine (2012) 0.75

Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines. Mol Biol Rep (2012) 0.75

Immunotherapy of mastitis. Vet Immunol Immunopathol (2013) 0.75

Differentiating infected from vaccinated animals, and among virulent prototypes of reovirus. J Virol Methods (2011) 0.75

Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypes. Vaccine (2011) 0.75